Image de couverture de livre

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Andrée‐Ann Baril, Cynthia Picard, Anne Labonté, Erlan Sanchez, Catherine Duclos, Béry Mohammediyan, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, John C. S. Breitner, Sylvia Villeneuve, Judes Poirier
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Synaptic proteins in pre‐symptomatic Alzheimer's disease: genes implicate synaptic biomarkers to the early detection of cognitive decline
par: Jiarui Ao, et autres
Publié: (2024)

Self‐reported and objectively assessed insomnia symptom severity and cognitive markers in dementia‐free older adults at‐risk for Alzheimer's disease
par: Bery Mohammediyan, et autres
Publié: (2025)

Complement proteins C1q, C3, and Factor H are associated with early tau pathology and synaptic integrity in persons with pre‐symptomatic Alzheimer’s disease
par: Julia Loncke, et autres
Publié: (2024)

Relationship between complement protein levels and tau pathology in pre‐symptomatic Alzheimer's disease resembles patterns observed in MCI
par: Julia Loncke, et autres
Publié: (2025)

The IL‐18 signaling cascade is implicated in aging, tau pathology and synaptic degeneration
par: Isabel MacKenzie Sarty, et autres
Publié: (2025)

Association between BrainAGE and Alzheimer's disease biomarkers
par: Yousaf Abughofah, et autres
Publié: (2025)

Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
par: Frederikke Kragh Clemmensen, et autres
Publié: (2026)

Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort
par: Joyce R. Chong, et autres
Publié: (2024)

Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia
par: Cassandra Marotta, et autres
Publié: (2025)

PTPRS is a novel marker for early tau pathology and synaptic integrity in Alzheimer’s disease
par: Alexandre Poirier, et autres
Publié: (2024)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
par: Sofia Toniolo, et autres
Publié: (2024)

Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals
par: Henry Gilreath Stephenson, et autres
Publié: (2025)

Cardiovascular rate pressure product is associated with NfL in older adults at risk for AD
par: Chinenye C. Odo, et autres
Publié: (2025)

Longitudinal association between CSF markers of Alzheimer Disease and inflammation in preclinical Alzheimer Disease
par: Isabel MacKenzie Sarty, et autres
Publié: (2024)

The Association of Prenatal Alcohol Exposure With Brain Development During the First 1000 Days of Life: A Systematic Review
par: Marin Pielage, et autres
Publié: (2024)

The role of clusterin and the variant rs11136000_T throughout the spectrum of Alzheimer’s disease
par: Marina Tedeschi Dauar, et autres
Publié: (2024)

Criterion and convergent validity of plasma biomarkers in early‐onset Alzheimer's disease: Initial findings from LEADS
par: Dustin B. Hammers, et autres
Publié: (2026)

Biofluid‐based biomarkers for tau pathophysiology in Alzheimer's disease
par: Henrik Zetterberg, et autres
Publié: (2025)

Cerebrospinal fluid YKL‐40 relates to white matter hyperintensity progression in females but not males over a 6‐year period
par: Amalia J. Peterson, et autres
Publié: (2025)

Artificial intelligence‐based diagnosis in fetal pathology using external ear shapes
par: Quentin Hennocq, et autres
Publié: (2024)

Web‐based LAS‐FNAME and blood biomarkers in autosomal dominant Alzheimer's disease
par: Christopher Gonzalez Corona, et autres
Publié: (2026)

Dengue fever as a cause of hemophagocytic lymphohistiocytosis
par: Noely Hein
Publié: (2015)

Screening tools for oropharyngeal dysphagia in stroke
par: Tatiana Magalhães de Almeida
Publié: (2015)

Placental and Fetal Brain Volumes in Congenital Heart Disease Are Smallest Among Fetuses With Genetic Abnormalities
par: Sonali Ajwani, et autres
Publié: (2025)

Perceptions of cognitive decline among American Indian and Alaska Native elders
par: Cole Allick
Publié: (2024)

Exploring the relationship between melanopsin gene variants, sleep, and markers of brain health
par: Ayeisha Milligan Armstrong, et autres
Publié: (2025)

The role of tau and amyloid pathology in neurosensory impairments during preclinical Alzheimer's disease
par: Daniel C Bowie, et autres
Publié: (2025)

Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
par: Marieclaire Overton, et autres
Publié: (2025)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
par: Thomas Claessen, et autres
Publié: (2025)

Impact of sleep disruptions on gray matter structural covariance networks across the Alzheimer's disease continuum
par: Xiao Luo, et autres
Publié: (2025)

Preclinical dementia rating scores are associated with plasma phosphorylated tau‐217
par: Qi Huang, et autres
Publié: (2025)

Clinical and demographic factors modify the association between plasma phosphorylated tau‐181 and cognition
par: Corey J. Bolton, et autres
Publié: (2024)

Investigating the relationship between sleep disturbances and white matter hyperintensities in older adults on the Alzheimer's disease spectrum
par: Farooq Kamal, et autres
Publié: (2024)

Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
par: Russell Banks, et autres
Publié: (2024)

Evaluation of two clinical Centiloid analysis products for 18F‐florbetapir PET in cognitively unimpaired elders
par: Frank P. DiFilippo, et autres
Publié: (2025)

Online46: Online cognitive assessments in elderly cohorts—The British 1946 birth cohort case study
par: Ziyuan Cai, et autres
Publié: (2025)

Task‐evoked pupillary responses as potential biomarkers of mild cognitive impairment
par: Julius Opwonya, et autres
Publié: (2024)

Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
par: John T. O'Brien
Publié: (2025)

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
par: Katharina Bolsewig, et autres
Publié: (2024)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
par: Darren M. Lipnicki, et autres
Publié: (2026)